methionine dependency cancer treatment pubmed ncbi abstract conventional chemotherapies showed limits notably patients advanced cancer therapeutic strategies identified metabolic abnormalities cancer cells offer opportunities human cancer cell lines primary tumors absolute requirements methionine essential amino acid contrast normal cells resistant exogenous methionine restriction biochemical mechanism methionine dependency studied extensively fundamental mechanism remains unclear number investigators attempted exploit methionine dependence tumors therapeutic effects vivo reduce vivo methionine plasma tumours dietary pharmacological treatments methionine-free diet methionine-deprived total parenteral nutrition regression variety animal tumours alternatively methionine depletion achieved methioninase enzyme specifically degrades methionine inhibits tumour growth preclinical models potential toxicity quality life problems prolonged methionine restriction diet methioninase suitable clinical methionine restriction find greater application association chemotherapeutic agents preclinical studies demonstrated synergy methionine restriction cytotoxic chemotherapy drugs experimental results accumulated decades suggest methionine restriction additional cancer therapeutic strategy notably association chemotherapy 
